Virtual Event: Attend virtually from anywhere.
7th Edition of Cardiology World Conference
October 08-10, 2026 | Virtual Event
Nephrocardiology
Nephrocardiology
Nephrocardiology includes the clinical conditions that involves both heart and kidney. If a person has kidney disease, he is more likely to get heart disease. Heart disease is a common cause of death among people who have kidney disease.
Kidney disease and heart disease shares mainly two causes:
Committee Members
Yochai Birnbaum
Baylor College of Medicine, United States
Uwe Peter Tigor
Auxilius Pharma, United States
Sekib Sokolovic
ASA Hospital, Bosnia and Herzegowina Cardio 2026 Speakers
Sergey Suchkov
N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Syed Raza
Awali Hospital, Bahrain
Sekib Sokolovic
ASA Hospital, Bosnia and Herzegowina
Thomas J Webster
Brown University, United StatesSubmit your abstract Today
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, TEDA International Cardiovascular Hospital, Tianjin University, China
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States